en
Scientific article
English

Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

Published inLiver International, vol. 38, no. 3, p. 424-431
Publication date2018
Abstract

Hepatitis C virus (HCV) therapies with interferon-free second-generation direct-acting antivirals (DAAs) are highly effective and well tolerated. They have the potential to increase treatment eligibility and efficacy in HIV-infected patients. We assessed the impact of DAAs on treatment uptake and efficacy, as well as its impact on the burden of liver disease in the Swiss HIV Cohort Study (SHCS).

Research group
Citation (ISO format)
BEGUELIN, Charles et al. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. In: Liver International, 2018, vol. 38, n° 3, p. 424–431. doi: 10.1111/liv.13528
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1478-3223
377views
0downloads

Technical informations

Creation11/06/2018 4:35:00 PM
First validation11/06/2018 4:35:00 PM
Update time03/15/2023 4:03:42 PM
Status update03/15/2023 4:03:42 PM
Last indexation05/03/2024 8:03:09 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack